Bogotá

MCCN Executes Extraction Agreement with Third-Party Cultivator

Retrieved on: 
Tuesday, June 8, 2021

The agreement is for MCCN to provide extraction services for La Finca.

Key Points: 
  • The agreement is for MCCN to provide extraction services for La Finca.
  • This executed commercial execution services agreement is the second such agreement that MCCN has entered into since launching its third-party commercial extraction services in May 2021.
  • MCCN is pleased with execution of this second commercial extraction agreement and is encouraged with the interest that has been received from Colombian cultivators with the potential of providing third-party extraction services in Colombia.
  • MCCN is to initially provide extraction services to La Finca for 26,000 kilograms of dried biomass every three months.

Medcolcanna Announces Mailing of Materials for AGM on July 7, 2021 and Provides Corporate Update

Retrieved on: 
Friday, June 4, 2021
Articles, Shareholder, Stock market, Business, Corporate law, Meetings, United Kingdom company law, English law, Shareholder committee

Shareholders will not be able to attend the annual general and special meeting in person.

Key Points: 
  • Shareholders will not be able to attend the annual general and special meeting in person.
  • Shareholders will have an opportunity to participate at the annual general and special meeting online regardless of their geographic location.
  • Non-registered (beneficial) shareholders who have not duly appointed themselves as proxyholders may still attend the virtual meeting as guests.
  • Guests will be able to listen to the meeting but will not be able to vote at the meeting.

MCCN Executes Extraction Agreement with International Cannabis Company

Retrieved on: 
Tuesday, June 1, 2021
Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Rosids, Cannabis, Cannabis smoking, Legality of cannabis

Bogota, Colombia--(Newsfile Corp. - June 1, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of an extraction service agreement with an International Cannabis Company, a company with formulations for health and wellness applications, for depression, anxiety and PTSD, which also has cultivation operations in Colombia.

Key Points: 
  • Bogota, Colombia--(Newsfile Corp. - June 1, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of an extraction service agreement with an International Cannabis Company, a company with formulations for health and wellness applications, for depression, anxiety and PTSD, which also has cultivation operations in Colombia.
  • This is the first commercial third-party extraction services agreement that has been executed after MCCN began offering extraction services to thirdparties in May 2021.
  • The counterparty to the Commercial extraction services agreement is an International Cannabis Company with formulations for health and wellness applications, for depression, anxiety and PTSD, and with cultivation operations in Colombia.
  • The International Cannabis Company will be delivering between 2,500 to 4,500 kilograms of dried cannabis biomass to MCCN extraction facilities every three months.

Medcolcanna Organics Signs Landmark Agreement with Industry Leader Industrial Hemp Farms (IHF)

Retrieved on: 
Thursday, May 27, 2021
Herbs, Biofuels, Hemp

This supply agreement would represent a minimum of $12 million USD ($14.5M CAD) on a rolling 12 month basis in revenue for MCCN.

Key Points: 
  • This supply agreement would represent a minimum of $12 million USD ($14.5M CAD) on a rolling 12 month basis in revenue for MCCN.
  • MCNN anticipates the CBD dried flower supply agreement to begin in Q4 2021, when regulations should be in place for the flower export.
  • IHF enjoys a commanding presence in the industry, being the third largest supplier of bulk hemp flower and extracts worldwide.
  • Medcolcanna assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

ADDI, Latin America’s leading Buy Now Pay Later (BNPL) Company raises $65mm in new funding to fund growth in Colombia and Brazil

Retrieved on: 
Wednesday, May 26, 2021
Companies, Banco Santander, IBEX 35, Banks, Santander, Spain, Financial services, Santander México

The new funding will be used to grow ADDIs business in Colombia and support its launch in Brazil.

Key Points: 
  • The new funding will be used to grow ADDIs business in Colombia and support its launch in Brazil.
  • The Company is also announcing today a strategic partnership with Banco Santander in Colombia.
  • ADDIs mission is to power digital commerce in Latin America, starting with Buy Now Pay Later.In just a few minutes, customers can buy from their favorite merchants and pay over time.
  • ADDI will use its new funding to fuel its expansion into Brazil, where it launched this year.

Medcolcanna Announces Postponement of AGM Scheduled for May 19, 2021

Retrieved on: 
Saturday, May 15, 2021
Medicinal plants, Herbalism, Entheogens, Euphoriants, Health sciences, Branches of biology, Cannabis, Cannabis smoking, Medical cannabis, Medicine

b'Bogot\xc3\xa1, Colombia--(Newsfile Corp. - May 14, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Wednesday, May 19, 2021 at 11:00 a.m. (Bogota time) at the offices of the Company will be postponed to a later date, with details of the new date and time to be provided in a future news release.

Key Points: 
  • b'Bogot\xc3\xa1, Colombia--(Newsfile Corp. - May 14, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Wednesday, May 19, 2021 at 11:00 a.m. (Bogota time) at the offices of the Company will be postponed to a later date, with details of the new date and time to be provided in a future news release.
  • Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market.\nMedcolcanna employs state of the art organic agricultural technology and innovative pharmaceutical processes to produce high-quality products.
  • Hard work and strong commitment have taken us here and we will relentlessly continue to fulfill our mission to bring high quality cannabis based products at highly competitive prices in order to help improve several medical conditions for patients in need.
  • "\nIf you would like to receive News Releases via email as soon as they are published, please subscribe here: https://medcolcanna.com/contact-us/ or write to [email protected] .\n'

Tecnoglass to Present at Sidoti Microcap Virtual Investor Conference

Retrieved on: 
Thursday, May 13, 2021
Finance, Money, Stock market, Financial markets, Intel X99, Microcap stock, Bogotá, Time in Colombia, Investor relations, NASDAQ

b'Barranquilla, Colombia, May 13, 2021 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NASDAQ: TGLS) ("Tecnoglass" or the "Company"), a leading manufacturer of architectural glass, windows, and associated aluminum products serving the global residential and commercial end markets, today announced that the Company will present at the Sidoti Microcap Virtual Investor Conference on Thursday, May 20, 2021 at 10:45 a.m. eastern time (9:45 a.m. Bogota, Colombia time).\nA live broadcast of the presentation, including presentation materials, may be accessed through the Investor Relations section of Tecnoglass\' website at www.tecnoglass.com .

Key Points: 
  • b'Barranquilla, Colombia, May 13, 2021 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NASDAQ: TGLS) ("Tecnoglass" or the "Company"), a leading manufacturer of architectural glass, windows, and associated aluminum products serving the global residential and commercial end markets, today announced that the Company will present at the Sidoti Microcap Virtual Investor Conference on Thursday, May 20, 2021 at 10:45 a.m. eastern time (9:45 a.m. Bogota, Colombia time).\nA live broadcast of the presentation, including presentation materials, may be accessed through the Investor Relations section of Tecnoglass\' website at www.tecnoglass.com .
  • Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural glass transformation company in Latin America.
  • These risks, uncertainties and contingencies are indicated from time to time in Tecnoglass\xe2\x80\x99 filings with the Securities and Exchange Commission.
  • Further, investors should keep in mind that Tecnoglass\xe2\x80\x99 financial results in any particular period may not be indicative of future results.

NBA Star and Television Personality John Salley Joins One World Pharma's Board of Advisors

Retrieved on: 
Monday, April 19, 2021
Salley, OWP, Bogotá, Administrative divisions

Salley would later win championships with the Chicago Bulls and Los Angeles Lakers.

Key Points: 
  • Salley would later win championships with the Chicago Bulls and Los Angeles Lakers.
  • Salley joins a growing Board of Advisors that is chaired by Minyon Moore , who is widely considered one of the nation\xe2\x80\x99s top strategic thinkers with extensive experience in political and corporate affairs as well as public policy.
  • OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide.
  • The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.\n'

Medcolcanna Organics is Granted Approximately 4% of Worlds Legal Production Quota of Medical Cannabis

Retrieved on: 
Friday, March 26, 2021
Herbalism, Medicinal plants, Health sciences, Appetite stimulants, Entheogens, Euphoriants, Psychoactive drugs, Branches of biology, Cannabis, Medical cannabis, Legality of cannabis

The Colombian Ministry of Health and Social Protection has passed Resolution 336 of 2021, specifically granting the quota of 4317 Kg.

Key Points: 
  • The Colombian Ministry of Health and Social Protection has passed Resolution 336 of 2021, specifically granting the quota of 4317 Kg.
  • to Medcolcanna for export market, and 990 kilos for the local market to sell psychoactive medicinal cannabis under prescription for patients through its well-developed strategy on partnerships with Curativa, Rappi, and Masana-Medicina Nueva.
  • Medcolcanna is a Canadian-integrated medical cannabis company, whose fully licensed operations are based in Colombia.
  • The Company's scalable production model and network of pharmaceutical partnerships globally ensures that they remain at the forefront of the medical cannabis industry.

Medcolcanna Organics Announces Closing of Bridge Loan Arrangement

Retrieved on: 
Wednesday, March 24, 2021
Loans, Money, Finance, Economy, Amortization, Bridge loan, Balloon payment mortgage, Negative amortization

Under the terms of the Bridge Loan, the Lenders provided an initial bridge loan financing amount of $275,000 for a two-year term at an annual interest rate of 7.85%, with interest payments completed quarterly and with amortization of same commencing fifteen months from the date of the loan.

Key Points: 
  • Under the terms of the Bridge Loan, the Lenders provided an initial bridge loan financing amount of $275,000 for a two-year term at an annual interest rate of 7.85%, with interest payments completed quarterly and with amortization of same commencing fifteen months from the date of the loan.
  • The Company is now pleased to announce that an additional amount of CDN$475,000 was made available pursuant to the Bridge Loan, bringing the total available loan which was ultimately advanced to CDN$750,000.
  • Payments on the principal of the Bridge Loan are deferred until fifteen months after the commencement of the Bridge Loan, unless certain financing events or positive cash flow milestones are achieved by the Company wherein repayment of the Bridge Loan would be accelerated.
  • As part of the Bridge Loan arrangement, 11.25 million warrants with an exercise price of $0.10 over a two-year term were issued to the Lenders.